Proteasome Inhibition Sensitizes Non–Small-Cell Lung Cancer to Gemcitabine-Induced Apoptosis

This publication has 23 references indexed in Scilit:

• Combined proteasome and histone deacetylase inhibition in non–small cell lung cancer
  The Journal of Thoracic and Cardiovascular Surgery, 2004
• Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt Pathway
  Journal of Biological Chemistry, 2003
• Role of Rel/NF‐κB transcription factors in apoptosis of human hepatocellular carcinoma cells
  Cancer, 2002
• NF-κB as a therapeutic target in cancer
  Trends in Molecular Medicine, 2002
• Active RB Elicits Late G1/S Inhibition
  Experimental Cell Research, 2002
• Inhibition of NF-κB sensitizes non–small cell lung cancer cells to chemotherapy-induced apoptosis
  The Annals of Thoracic Surgery, 2000
• The Hallmarks of Cancer
  Cell, 2000
• Control of apoptosis by Rel/NF-κB transcription factors
  Oncogene, 1999
• TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
  Science, 1996
• Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"
  Nature, 1990